Biotech Week articles from June 2003

Biotech Week archives from June 2003

Hepatitis A vaccine does not affect course of HIV.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Hepatitis A vaccination did not affect the course of HIV infection in HIV-positive patients. "The safety and immunogenicity of inactivated hepatitis A (HepA) vaccine was assessed in 133 hepatitis A...

Protein mimetics could lead to more successful heart surgery.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Severe spasm of blood vessels contributes to the failure of coronary bypass surgeries and to strokes following the rupture of an aneurysm in the brain. A complex signaling pathway controls relaxation in...

Nonmyeloablative conditioning enables marrow-induced tolerance.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A nonmyeloablative conditioning regimen enables the induction of transgenic tolerance through bone marrow transplantation, according to researchers in Boston....

HPLC/electrospray ionization MS detects choline, acetylcholine in preparations.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline scientists have described "a sensitive, rapid, and specific method for the detection of choline and acetylcholine in a pharmaceutical preparation." R. Dunphy and colleagues...

Newer drug has worse side effects than older drug.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Two commonly prescribed epilepsy drugs have varied cognitive side effects, report doctors from Georgetown University Medical Center. In a double-blind, randomized study, researchers looked at two...

A novel integrin antagonist induces apoptosis in angiogenic endothelial cells.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- According to a study from Canada, "Integrin-mediated cell adhesion is necessary for endothelial cell proliferation and apoptosis, which is a major determinant in tumor-induced angiogenesis. In this...

Patented stem cell expansion technology acquired.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- A.I. Software, Inc., (ASOW) announced that it has reached an agreement with the Weitzman Institute of Science and Technion - Israel Institute of Technology to acquire the exclusive rights of stem cell...

Employees at pharma company rewarded for superior performance.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories (ABT) announced that 26 Abbott employees were honored with the company's chairman's award. This award is one of the company's highest honors and is given to employees who...

Vaccine producer provides updates on corporate programs.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Acambis plc (ACAM) announced its results for the first quarter ended 31 March 2003. During the first quarter of 2003, there were a number of positive developments relating to our smallpox vaccine...

Enterotoxin H induces Valpha-specific T-cell expansion.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Staphylococcal enterotoxin H (SEH) triggers Valpha-specific T-cell expansion. SEH "is a bacterial superantigen secreted by Staphylococcus aureus," researchers in Sweden explained. "Superantigens are...

Studies demonstrate potential clinical utility of siRNA in ophthalmic disease.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Acuity Pharmaceuticals, a new pharmaceutical company, and the University of Pennsylvania released research conducted by scientists affiliated with the two organizations that supports the potential...

Recruitment services help enroll more than 100 protocols to date.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Acurian announced that since launching AcuPatient, its Direct-to-Patient (DTP) recruitment service for the rapid enrollment of clinical trials, and AcuSite, its database service for the identification...

Contrast agent assists in accurate detection of lymph node disease.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Advanced Magnetics, Inc., (AVM) and Cytogen Corp. (CYTO) announced the presentation of data showing that magnetic resonance (MR) imaging plus an investigative contrast agent (ferumoxtran-10, Combidex)...

Cancer drug maker reports first quarter results, adoption of stockholder rights plan.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) reported financial results for the first quarter 2003. For the 3 months ended March 31, 2003, the company reported a net loss of $7.1 million, or $0.28 per share....

Grant awarded to develop gene expression analysis for cancer.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Althea Technologies, Inc., announced that it has received a phase I Small Business Innovation Research grant from the U.S. National Institutes of Health, by way of the National Cancer Institute (NCI),...

Calcitriol launched for hypocalcemia.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- American Pharmaceutical Partners, Inc., (APPX) announced the launch of calcitriol for injection with shared 180-days of marketing exclusivity. Calcitriol, the generic equivalent of Abbott Laboratories,...

Glycoengineering enhances in vivo activities.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Glycoengineering enhances and prolongs the activity of protein therapeutics, according to a report from Amgen, Inc., California. "Delivery of protein therapeutics often requires frequent injections...

Pharmaceutical firm reports net loss of $0.34 per share.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Amylin Pharmaceuticals, Inc., (AMLN) reported a net loss of $30.8 million, or $0.34 per share, for the first quarter ended March 31, 2003, compared to a net loss of $22.1 million, or $0.30 per share,...

Biotech company reports results in line with guidance for first quarter.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Array BioPharma, Inc., (ARRY) reported financial results for the third quarter of fiscal 2003, ended March 31, 2003. During the third quarter of fiscal 2003, Array reported total revenue of $8.0...

Utah clinical reference lab announces sublicense agreement with InVivoScribe.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- ARUP Laboratories, Inc., (Associated Regional and University Pathologists, Inc.), a Utah-based clinical reference laboratory, announced that it has secured a sublicense from InVivoScribe Technologies to...

Iressa approved by FDA.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- AstraZeneca Pharmaceuticals (AZN) announced that the U.S. Food and Drug Administration (FDA) has granted approval for Iressa (gefitinib) for the treatment of advanced non-small-cell lung cancer (NSCLC)....

NIH grant awarded to generate antibodies to CMV; 1Q finances reported.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Avanir Pharmaceuticals (AVN) announced it has been awarded a grant from the U.S. National Institutes of Health (NIH) under its phase I Small Business Innovation Research (SBIR) program. The company also...

Lantus receives FDA approval for flexible administration.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Aventis announced that its basal insulin, Lantus, has been approved by the U.S. Food and Drug Administration for flexible administration at any time of day. Lantus is the first and only basal...

High cholesterol and sugar diet impairs insulin sensitivity in rats.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- A cholesterol- and sucrose-rich diet promoted lipoprotein peroxidation and impaired insulin sensitivity in rats. "The effects of a diet rich in cholesterol and sucrose on lipoprotein peroxidation...

A new table-fixed retractor facilitates anterior odontoid screw fixation.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- A new table-fixed retractor facilitates anterior odontoid screw fixation. Investigators in the United States report on "...a unique retraction device adapted for anterior odontoid screw placement."...

Repetitive coulomb-controlled iontophoresis delivers medications topically.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Repetitive coulomb-controlled iontophoresis has potential to deliver topical drug therapy to the eye without the side effects that can occur with systemic delivery of nonsteroidal anti-inflammatory...

New leadership promotions announced at healthcare firm.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Baxa Corporation announced key promotions in its leadership. Greg Baldwin has taken the position of chairman of the board of directors, in addition to his role as CEO. Jeff Baldwin has been...

Executive appointments announced by HRT producer.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Reinhard Franzen, the new CEO of Berlex Laboratories, Inc., the U.S. affiliate of Schering AG, Germany (SHR), announced appointments to his executive team. "Our parent company has long-term...

Aldurazyme maker reports loss of $0.35 per share.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- BioMarin Pharmaceutical, Inc., (BMRN; BMRN) announced financial results for its first quarter ended March 31, 2003. The company incurred a loss of $19.7 million ($0.35 per share) in the first...

Watkins named VP of business development at pharma company.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Paul C. Watkins, an experienced biotech and pharmaceutical executive, has been appointed VP of business development for BioMarker Pharmaceuticals, Inc. "Paul Watkins will lead our efforts to...

Positive phase II/III trial results reported for estradiol topical gel.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BISP) announced that an effective dose of Bio-E-Gel (estradiol topical gel) has been identified in its phase II/III clinical trial for the treatment of...

Lawsuit filed over intellectual property.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Biolase Technology, Inc., (BLTI) filed suit against Diodem LLC on May 2, 2003, to reinforce Biolase's intellectual property position in the marketplace. Diodem, LLC is a small, recently formed...

Final repayment, cancellation of convertible debentures announced.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM; BRA) announced that it has repaid in full the outstanding principal and interest with respect to its U.S. $15 million private financing of convertible debentures announced on...

Richard L. Jackson joins board of cancer vaccine company.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM) and its chairman, Eric Baker, announced the appointment of Richard L. Jackson, PhD, to its board of directors. Jackson is the principal of Jackson Associates, Inc., a...

Update provided on regulatory filings for diabetes drug in Mexico.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Robert Rieveley, president of Biotech Holdings, provided an update on regulatory filings in Mexico for Sucanon, Biotech's type II diabetes drug. We are pleased to report that we have filed, as...

Biotech company announces governance actions.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced several actions related to the governance of the company. The company held its annual meeting of shareholders, during which John E. Pepper was elected...

Pharmaceutical company to list on NYSE.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Bradley Pharmaceuticals, Inc., (BPRX) announced its listing on the NYSE from the Nasdaq Stock Exchange, effective May 13, 2003. The company's shares will be traded on the NYSE under the new symbol...

Short-term treatment for sleep disorder acquired.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb Company (BMY) announced that its subsidiary Mead Johnson & Company has signed a purchase agreement with OPR Development, L.P. to acquire Cafcit (caffeine citrate) Injection and Oral...

Development program to develop water soluble polymer technology.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Carrington Laboratories, Inc., (CARN) announced the formation of a relationship between its DelSite Biotechnologies, Inc., subsidiary and the University of Southern Mississippi (USM) to initiate a...

Nasal vaccine delivery platform data presented at vaccine conference.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Carrington Laboratories, Inc., (CARN) announced that results of an initial study sponsored by its subsidiary DelSite Biotechnologies, Inc., were presented at the 6th Annual Conference of Vaccine...

Revenue climbs 85% for drug delivery company.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Carrington Laboratories, Inc., (CARN) reported that first quarter revenues climbed nearly 85% to $6.9 million from $3.7 million a year earlier. The net loss for the quarter ended March 31, 2003,...

Biotech firm president, CEO express confidence in company.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Cel-Sci Corporation (CVM) reports that Cel-Sci's president Maximilian de Clara and Cel-Sci's CEO Geert Kersten have elected to take 6 months of salary in the form of company stock. This stock is...

Endothelial progenitor-like cells are angiogenesis-selective gene vectors.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Endothelial progenitor-like cells are angiogenesis-selective gene vectors. According to recent research from Canada, "human and mouse proliferation-competent, bone marrow or peripheral circulation...

Provigil maker reports product sales of $137.6M.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Cephalon, Inc., (CEPH) reported results for the first quarter of 2003, which included total revenue of $144.7 million, product sales of $137.6 million, and diluted earnings per share of $0.21. ...

Modified gagpol fusion gene highly immunogenic in animals.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A novel fusion of the HIV gag and pol genes is highly immunogenic in animals, researchers in California report. "Results of both natural history studies and...

Watson expands alliance with Cipla, Ltd.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Watson Pharmaceuticals, Inc., (WPI) a specialty pharmaceutical company, announced the expansion of its generic product development alliance with Cipla, Ltd. Under the terms of the expanded...

Antisense transcription in the human genome may be a common occurrence.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Antisense transcription in the human genome may be a common occurrence. "An increasing number of eukaryotic genes are being found to have naturally occurring antisense transcripts. Here we study the...

Method for determination of fluconazole in human plasma described.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- A bioanalytical method that uses automated sample transferring, automated liquid/liquid extraction (LLE) and hydrophilic interaction liquid chromatography-tandem mass spectrometry has been developed by...

Selective amplifier genes containing c-Mpl augment hematopoietic cell expansion.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Selective amplifier genes containing c-Mpl augment hematopoietic cell expansion. "We previously developed 'selective amplifier genes (SAGs)' which confer a growth advantage to transduced cells. The...

Michael Deines named vice president of marketing.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Dharmacon, Inc., a global supplier of innovative RNA and RNA-interference (RNAi) research products, announced the appointment of Michael Deines to the newly created position of vice president of...

Disposition of a synthetic analogue of lipid A studied in rats.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Eisai & Co. Ltd. (Japan) is developing a treatment for sepsis resulting from Gram-negative bacterial infections. Company scientists recently characterized the disposition of the compound, E5564, a lipid...

Neurogenetics licenses a phase II AMPA/Kainate receptor.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Neurogenetics, Inc., a privately held biopharmaceutical company, announced an agreement to license and further develop a compound from Eli Lilly and Co. The compound has a unique mechanism of action...

Clinical studies initiated for a new insulin capsule; financial results reported.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Emisphere Technologies, Inc., (EMIS) announced that it is initiating clinical testing of an oral insulin formulation in type 2 diabetic patients in the United States under an Investigational New Drug...

Technology provider selected to deliver comprehensive infrastructure.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- eResearchTechnology, Inc., (eRT) (ERES), an e-research technology and services provider, announced that it has entered into an agreement with Endocyte, Inc., to provide an integrated technology and...

Genomics company reports net loss of $0.03 per share.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Epoch Biosciences, Inc., (EBIO), a provider of proprietary products that accelerate genomic analysis, reported that revenues for the first quarter increased to $2.4 million compared to $2.3 million in...

Commercial lab test available.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Focus Technologies announced that the company has developed a first-generation real-time PCR test designed to detect the presence of the coronavirus associated with the development of severe acute...

Memantine fails to demonstrate efficacy.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Forest Laboratories, Inc., (FRX) announced that a just completed pivotal placebo-controlled study of memantine in the treatment of neuropathic pain in diabetic patients had failed to demonstrate a...

Oncology drug maker reports strong results for first quarter 2003.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- GPC Biotech AG (GPC) reported on its successful course of business for the first quarter of 2003. For the 3 months ended March 31, 2003, revenues increased 20.5% to EUR 6.1 million, compared to EUR...

Antiangiogenic drug maker has $0.04 per share loss; clinical progress updated.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Genaera Corporation (GENR) announced its financial results for the quarter ended March 31, 2003, and promising early results for the phase I-II clinical trial of its anti-angiogenic drug, squalamine,...

Kaplan named senior VP, chief financial officer at pharmaceutical firm.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Genaissance Pharmaceuticals, Inc., (GNSC) announced that it has appointed Ben D. Kaplan to the position of senior VP and chief financial officer (CFO). "Ben is an accomplished financial executive...

$8.1M raised in private placement financing at biotech company.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Genelabs Technologies, Inc., (GNLB) announced that it has completed the sale of 8.1 million shares of its common stock to institutional and accredited investors at a price of $1.00 per share, for gross...

Drug fails key test.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- The biologically engineered drug Raptiva failed to effectively treat rheumatoid arthritis patients in a key experiment, its manufacturers say. The companies said they are halting further tests on...

Aerosol formulation patent accepted in New Zealand.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corporation (GNBT) announced that it has received a Notice of Acceptance from the Intellectual Property office of New Zealand. The patent relates to aerosol formulations for...

Federal district court upholds Ceftin patent.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline (GSK) announced that a federal judge for the United States District Court for the Northern District of Illinois in Chicago has ruled in patent litigation involving GSK's drug Ceftin...

Loan agreement; restructuring releases $40M of working capital.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Guilford Pharmaceuticals, Inc., (GLFD) announced it has entered into an $18.8 million term loan with Wachovia Bank to restructure the synthetic lease on the company's research and development facility...

Murine model can aid trehalose and trehalase analyses.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Scientists with Hayashibara Biochemistry Laboratories, Inc., Okayama, Japan, have created trehalase-deficient (treh -/-) mice as a model for the study of trehalose and trehalase mechanisms and...

Wilds, Fiddes named to board of early-stage biotech company.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Helix BioMedix, Inc., (HXBM) an early-stage biotechnology company, announced that Daniel O. Wilds and John C. Fiddes, PhD, have joined the company's board of directors. Wilds has more than 30 years...

R&D alliance to focus on cell, gene therapy at Baylor College of Medicine.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Hemispherx Biopharma, Inc., (HEB) announced that it has entered into a Research Project Agreement with the prestigious Center for Cell and Gene Therapy at the Baylor College of Medicine in Houston,...

Specialty pharmaceuticals company reports first quarter profit.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- ICN Pharmaceuticals, Inc., (ICN) announced first quarter 2003 results. For the quarter ended March 31, 2003, revenues were $158.7 million, compared with $185.0 million in the same period last year....

New data released on plague, strep vaccines.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- ID Biomedical has confirmed that nasal Proteosome-based vaccines protect against pneumonic Plague caused by lethal aerosol infection with virulent Plague bacteria in a mouse model of airborne...

Companies announces antiviral strategic alliance and equity transaction.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Idenix Pharmaceuticals, Inc., announced that Novartis Pharma, AG, an affiliate of Novartis, AG, (NVS), completed the purchase of 51% of the capital stock of Idenix on a fully diluted basis. The...

Progress in immunoconjugate technology has revitalized the magic bullet concept.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Progress in immunoconjugate technology has revitalized the magic bullet concept. "Advances in immunoconjugate technology have revitalized the 'magic bullet' concept of immunotherapeutics for the...

Patent granted for method of labeling antibodies; finances reported.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Immunomedics, Inc., (IMMU) announced quarterly finances and the recent issuance of U.S. Patent No. 6,558,669 covering the company's proprietary method of labeling antibodies with Iodine-131. The...

Net loss reported at $0.11 per share by catalytic antioxidants developer.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Incara Pharmaceuticals Corporation (INCR) announced the financial results for its second quarter of fiscal 2003, the 3-month period ended March 31, 2003. Incara reported a net loss attributable to...

Results from first clinical study of Veronate released.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- At the annual meeting of the Pediatric Academic Societies in Seattle, Washington, Inhibitex presented results from its first study of Veronate. Veronate is an antibody-based product currently under...

Pharmaceutical company appoints executives.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Inspire Pharmaceuticals, Inc., (ISPH) announced the appointment of Thomas R. Staab, II, to the position of chief financial officer of Inspire. Staab will be responsible for the finance and...

Phase II trial data released on Pirfenidone.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- InterMune, Inc., (ITMN) announced that data from a phase II trial of pirfenidone for pulmonary fibrosis suggests the drug may be more efficacious than prednisone in patients with idiopathic pulmonary...

Hepatitis C drug maker reports quarterly loss, provides program updates.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Isis Pharmaceuticals, Inc., (ISIS) announced its financial results for the first quarter of 2003. Total revenue for the 3 months ended March 31, 2003, totaled $14.0 million, compared with $18.0...

Spectrum announces FDA acceptance of ANDA filing for ciprofloxacin.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Spectrum Pharmaceuticals, Inc., (SPPI) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its abbreviated new drug application (ANDA) for ciprofloxacin. The filing...

More convenient form of Risperdal now available.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- A new, fast-dissolving form of the schizophrenia medication Risperdal (risperidone) has been launched. Risperdal M-TAB dissolves in seconds when placed on the tongue. Risperdal, marketed by Janssen...

Johnson & Johnson awards $180,000 grant for drug research.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- What do leukemia, the evergreen plum-yew tree in southeast Asia, and California Institute of Technology faculty member Brian Stoltz have in common? Stoltz, an assistant professor of chemistry, is...

Cardiovascular disease clinical trial initiated with NIH grant.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Juvenon, Inc., announced the initiation of a clinical trial to evaluate the effect of Juvenon Energy Formula on cardiovascular disease patients. The trial, funded by a grant from the U.S. National...

Pharmaceutical company reaffirms intent not to proceed; reports 1Q financials.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- King Pharmaceuticals, Inc., (KG) reaffirmed its position that the asset purchase agreement dated January 30, 2003, with Elan Corporation, plc, concerning the purchase of Elan's primary care business,...

Second quarter of profitability reported by cholesterol drug maker.
June 4, 2003... 2003 JUN 4 - (NewsRx.com & NewsRx.net) -- Kos Pharmaceuticals, Inc., (KOSP) announced financial results for the first quarter ended March 31, 2003. For the first quarter of 2003, revenue increased 101% to a record $68.3 million, up from...